MSB 0.46% $1.09 mesoblast limited

Cell Therapy News/Articles, page-4647

  1. 208 Posts.
    lightbulb Created with Sketch. 133
    So plan is, csl buys out mesoblast in order to treat COVID with the synergistic therapy for $50/share until they develop a vaccine
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.005(0.46%)
Mkt cap ! $1.238B
Open High Low Value Volume
$1.09 $1.11 $1.08 $1.159M 1.066M

Buyers (Bids)

No. Vol. Price($)
26 52192 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.09 63760 14
View Market Depth
Last trade - 10.55am 10/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.